Why can one person take a small dose of a medication and feel overwhelmed by side effects, while another takes the usual dose and feels very little?
When you live with bipolar disorder, those differences can feel deeply personal. You may wonder whether something is wrong with you, whether treatment is worth trying, or whether you will ever find the right balance.
But a medication that does not suit you is not a personal failure. Part of the explanation may be how your body processes it, and your genes can help shape that process.
Pharmacogenomics, the study of how genetic differences affect medication response, offers one way to make treatment more individual. It cannot promise the perfect prescription. It can, however, give you and your care team useful information about certain medications, their doses, and the risk of side effects.
Just as importantly, better treatment does not depend on genetic testing alone. It also depends on honest conversations, practical support from pharmacists, and a plan that takes your whole life into account.
This article is educational and is not a substitute for individualized medical advice. Discuss medication choices, side effects, dose changes, and stopping treatment with your healthcare professional.
We are used to measuring blood pressure, blood sugar, and cholesterol. We can be less consistent about asking how someone is actually managing from day to day.
Yet mental health affects our ability to manage everything else. Living with diabetes, recovering from a heart attack, or handling several chronic conditions becomes more difficult when depression or other mental health symptoms are not being addressed.
For many of us, the first place we ask for help is not a psychiatrist's office. It is our GP or primary care clinic.
Primary care means the general healthcare professional you turn to for everyday health concerns and ongoing care. Depending on the setting, that may be a family doctor, nurse practitioner, or physician assistant. They can provide a foundation and help us navigate more specialized services.
That role matters because access to psychiatry and psychology is not always immediate. There may be long waiting lists, limited local services, or a gap in care after moving somewhere new. Primary care professionals need support to help people safely during that time, including people with bipolar symptoms or an established bipolar diagnosis.
Tools such as the PHQ-9 and the shorter PHQ-2 help primary care teams assess depressive symptoms. They give the conversation some structure, but a score is not the whole person.
If symptoms change, or the picture is more complicated than depression alone, the next step is to look deeper. We need to talk about what is happening in daily life, not simply record a number and move on.
I have collected medication from a pharmacy without really understanding everything happening behind the counter. It is easy to think of the visit as a transaction: arrive, collect the box, leave.
But pharmacists are medication experts. Some work directly in clinics alongside prescribers, helping review and manage treatment. Others work in community pharmacies, where they can help explain prescriptions, identify interactions, and make sense of side effects.
The difficulty is that access to that expertise varies. At a busy pharmacy, the person handing over your prescription may be a technician or clerk. The pharmacist may be dealing with many competing demands.
That does not mean your questions are unimportant. It means you may need to ask specifically to speak with the pharmacist, or arrange a conversation at another time.
A useful opening is simply to explain that you have never taken this medication before and want help getting started.
Medical appointments can be emotional. You may receive a diagnosis, discuss treatment, and hear a long list of instructions in a short time. None of us absorbs everything perfectly in those circumstances. A pharmacy conversation is another opportunity to understand the plan.
Rather than feeling you should somehow know the right questions, start with these:
The goal is not just to take the medication. It is to understand how to give the treatment a fair, safe trial.
Your pharmacist may not have a complete picture of everything you take. Some prescriptions may come from another pharmacy or a mail-order service. Supplements and occasional substance use may not appear anywhere in your medical record.
Bring a written list that includes:
This is not about being judged. It is about giving someone the information they need to check for possible interactions.
If the pharmacy is too busy for a thorough discussion, ask whether you can leave the list and receive a call later. A clear request for a medication and supplement review is much easier to act on than an unanswered question at a crowded counter.
Instructions only help if they fit the life you are actually living.
I once had a prescription for an antibiotic with a warning about sun sensitivity. I was about to go on holiday, swimming and spending time outdoors. Instead of pretending that avoiding the sun would be easy, I told my pharmacist that I did not think I could manage it properly.
That honesty led to a discussion about the timing of that particular treatment. It was not a reason to delay medication on my own. It was a reminder that practical details can change the conversation.
The same applies to daily routines. If remembering a new dose is difficult, discuss a consistent time or an alarm. If a particular medication has food restrictions, ask exactly what they mean. Sometimes a treatment appears unsuccessful because the instructions were never clear enough to follow.
The leaflet inside a medication box can be frightening. It may list everything from mild nausea to rare, serious events, without making it easy to understand what deserves your attention first.
Reading it alone can leave you with more anxiety than clarity.
A pharmacist can help put the information into context: what is common, what may improve as your body adjusts, what can be managed, and what needs medical attention. The question is not which warnings to ignore. It is how to understand and respond to them.
Sertraline, also known as Zoloft, provides a useful example. It belongs to the SSRI class of antidepressants, which affect serotonin signaling.
Serotonin is a chemical messenger involved in mental health, but its activity is not limited to the brain. It also has important roles in the gut. Changes in serotonin signaling can therefore contribute to nausea or diarrhea, especially when treatment begins.
This helps explain why a medication intended to affect mood can also upset your stomach. It does not mean everyone will experience those effects, or that nausea proves the medication will improve your mood.
Depending on the medication and your circumstances, your pharmacist and prescriber may discuss timing, a lower starting dose, or another way to make the beginning more manageable. Those are treatment decisions to make together, not adjustments to make by yourself.
Other people living with the same condition can offer valuable support. They may describe experiences that help you feel less alone or give you language for something you are struggling with.
But information shared in a community is not always accurate, and another person's response does not predict yours.
A useful approach is to bring what you have heard back to your pharmacist or doctor: explain the concern and ask whether it applies to your medication, dose, and health situation.
One of the hardest parts of starting mental health treatment is that side effects can arrive before the benefits.
You are already struggling. You begin a medication because you want to feel better. Then you may feel nauseous, dizzy, or otherwise uncomfortable while the symptoms you hoped to treat are still there.
That period can make it tempting to decide the treatment is not working. Sometimes a medication really is not the right fit. But early discomfort alone does not answer that question.
Ask your team for a realistic plan:
I understand the appeal of immediate relief. In the past, I used cannabis during hypomanic periods because I felt an effect quickly. Waiting days or weeks for prescribed treatment felt very different.
But immediate relief and long-term stability are not the same goal. That personal experience is not a recommendation to self-treat, and the speed of an effect does not, by itself, tell us whether something is safe or beneficial.
Lithium can be an effective treatment for bipolar disorder, but it requires monitoring to help keep blood levels within an appropriate range.
That process can feel intimidating. Repeated tests and dose adjustments may make you feel more like an experiment than a person. Still, the monitoring gives the care team information they can use alongside your symptoms and side effects.
Many other medications are not routinely monitored through drug blood levels. That is one reason genetic information can be useful for some treatments: it may help explain differences in medication exposure that would otherwise be difficult to see.
Pharmacogenomics sounds complicated, but the basic idea is approachable.
Two genes often discussed in psychiatric medication management are CYP2D6 and CYP2C19. They provide instructions for enzymes that help process many medications.
Think of those enzymes as little Pac-Man characters, working largely in the liver. Depending on the medicine, they may help break it down so the body can clear it, or help convert it into an active form.
Not everyone's Pac-Man works at the same speed.
The effect depends on the particular medication, especially when processing is needed to activate it. The Pac-Man image is a starting point, not a universal dosing rule.
Escitalopram, sold as Lexapro, and citalopram, sold as Celexa, are examples of antidepressants whose metabolism is influenced by CYP2C19.
Someone with low CYP2C19 activity may have higher exposure at a usual dose and find side effects harder to tolerate. Someone who metabolizes the medication very quickly may have lower exposure and little improvement.
Either experience can be discouraging. One person may conclude they cannot tolerate medication. Another may wait through the expected trial period and feel that treatment has done nothing.
Understanding metabolism can help a clinician interpret those experiences. These antidepressant examples explain the principle; they are not recommendations for a particular person's bipolar treatment.
A medication not helping you does not mean you have failed. It means your treatment needs another look.
The promise of precision psychiatry is not that a test will reveal your perfect medication. It is that useful information can help make a decision less dependent on trial and error.
For certain medications, pharmacogenomic results may help a clinician consider:
But these tests have important limits.
They do not diagnose bipolar disorder, guarantee effectiveness, or explain every side effect. Medication response has many influences. A result is one part of the clinical picture, alongside your history, current symptoms, other treatments, and preferences.
Reports may describe someone as a poor, intermediate, normal, rapid, or ultrarapid metabolizer for a particular enzyme. An intermediate result, for example, suggests reduced activity compared with normal metabolism, but it does not automatically translate into one clear action for every drug.
The decision still needs interpretation. It is similar to using another laboratory result: the number matters because of what it means for the person and the treatment under consideration.
Likewise, taking a low dose does not prove that you metabolize a medication slowly. It may raise a question, but it is not a genetic result.
In some clinical settings, genetic testing has become easier to obtain and less costly than it once was. However, access, panels, and costs differ between countries and healthcare systems.
Another barrier is professional confidence. A clinician may reasonably hesitate to order a test if they are unsure how to interpret it or use it to guide care.
This is where collaboration with a pharmacist experienced in pharmacogenomics can help. Ordering a test is only one step. Understanding whether it changes a decision is the useful part.
Panels also differ. Some examine medication-processing genes, while others include broader genetic information. They are not interchangeable, and a broader panel is not automatically more useful for the question you want answered.
You do not need to arrive with a genetics vocabulary. You can start with the treatment problem you want to understand.
Perhaps you have had unusually strong side effects. Perhaps several medications have provided little benefit. Or perhaps you are considering a new prescription and want to know whether testing could help guide it.
Questions worth asking include:
Some tests can use a cheek swab. The appropriate test and collection method depend on the service and clinical question.
If you take several medications, ask about the whole list. CYP2D6 and CYP2C19 affect medicines beyond psychiatry, and other enzymes can matter too.
The point is not to collect data for its own sake. It is to support a shared decision. An explanation of why a particular dose fits your situation can feel very different from being handed a prescription without understanding the reasoning.
This question carries a lot of emotion. It did for me.
Taking tablets every day is not enjoyable. But in my own life, the benefit has been much greater than that inconvenience. At the moment, I do not see a reason to stop. That is my experience, not a decision I can make for anyone else.
A more useful conversation than simply asking whether treatment is “forever” may be to ask what it is doing for your quality of life, what burdens it creates, and how the plan should be reviewed over time.
Many treatments for chronic conditions are about ongoing management and prevention, not a short course that makes the condition disappear. There is nothing shameful about needing long-term support.
Equally, you should be able to say that side effects are unacceptable, that you want to explore another option, or that you are considering stopping.
Be honest about wanting a change, but do not stop or alter medication on your own. Depending on the treatment, a careful reduction, replacement, and follow-up plan may be needed. Feeling stable is a reason to review the plan thoughtfully, not proof that treatment is no longer contributing.
Your psychiatrist, GP, pharmacist, psychologist, and other supporters can each bring different expertise. But you bring something nobody else can replace: the experience of living your life.
You know which side effects interfere with work, which routines are realistic, and what stability means to you.
I like the idea that we are the captain of our own care. That does not mean we have to navigate alone or know every answer. It means our goals and preferences belong in the conversation.
Mental health bias can still appear in healthcare. A treatment that helps someone live well should not be treated as something to remove simply because it is a psychiatric medication.
Imagine someone whose blood pressure is controlled by treatment. We would want a clear clinical reason to change it. Mental health deserves the same thoughtful approach.
If a professional dismisses your experience or makes you feel ashamed of benefiting from treatment, it is reasonable to seek another opinion or a more supportive provider where possible. This matters especially when primary care is your main source of support while specialist care is unavailable.
Genetic testing can add useful information. Medication can be an important part of care. Neither replaces a broader plan.
For me, stability comes from several connected sources: psychiatric care, psychological support, peer support, family, protecting sleep, paying attention to food and activity, being careful with alcohol, and taking my treatment.
Someone else may find their preferred activity in running, surfing, or yoga. The details will differ because our lives differ.
The important point is that lifestyle support is part of care, not a test of whether we can overcome a health condition through enough discipline. Bipolar disorder, depression, and anxiety deserve serious, individualized management, just as other health conditions do.
Your DNA may help explain one part of your medication response. Your voice helps the team understand the rest. Ask for clear explanations, share the information they may be missing, and speak up when something is not working for you.
You deserve care that is more precise, more collaborative, and free from shame.
For more resources and support around living with bipolar disorder, visit HopeStage.
